دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 12,000,000 تومان- قیمت ویژه : 6,250,000تومان
دسترسی ۳ ماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 93 ﺭﻭﺯ
قیمت : 4,000,000 تومان- قیمت ویژه : 1,750,000تومان
Bicarbonate in AKI and acidemia to reduce mortality and need for kidney replacement therapyÂ
doi : 10.1093/ckj/sfaf398
Volume 19, Issue 1, January 2026
Implementing a model of integrated CKD management between primary and secondary careÂ
doi : 10.1093/ckj/sfaf335
SGLT2 inhibitors in hemodialysis or peritoneal dialysis patients: rationale and state-of-the artÂ
doi : 10.1093/ckj/sfaf350
Mechanism of reduced intestinal phosphate absorption by tenapanor: a hypothesisÂ
doi : 10.1093/ckj/sfaf375
Ten tips on the work-up and management of CKD patients with nephrolithiasisÂ
doi : 10.1093/ckj/sfaf353
Molecular mechanisms in podocytopathies: finding suitable targets for a new era of glomerular gene therapyÂ
doi : 10.1093/ckj/sfaf332
The 2025 KDIGO guideline on the management of nephrotic syndrome in children: a comment of the European Renal Association Immunonephrology Working GroupÂ
doi : 10.1093/ckj/sfaf381
Unravelling sex-specific differences in autosomal dominant polycystic kidney disease: a multiorgan perspectiveÂ
doi : 10.1093/ckj/sfaf359
Prognostic relevance of persistent haematuria in patients with lupus nephritisÂ
doi : 10.1093/ckj/sfaf348
Biopsy-proven tyrosine kinase inhibitor–associated renal injury: a case seriesÂ
doi : 10.1093/ckj/sfaf394
Complement activation in anti-glomerular basement membrane disease before and after treatment with imlifidaseÂ
doi : 10.1093/ckj/sfaf393
Rituximab for the treatment of immune checkpoint inhibitor–induced glomerulonephritisÂ
doi : 10.1093/ckj/sfaf373
Higher blood flow rates in anticoagulation-free CRRT improve circuit survival and clinical outcomeÂ
doi : 10.1093/ckj/sfaf360
Prediction of hospital mortality in sepsis-associated acute kidney injury using a machine-learning approach: a multicenter study using SHAP interpretability analysisÂ
doi : 10.1093/ckj/sfaf372
Low protein diet with personalized support in advanced chronic kidney disease: association with disease progression, dialysis delay and mortalityÂ
doi : 10.1093/ckj/sfaf341
International variations in chronic kidney disease patients’ pain experience and its managementÂ
doi : 10.1093/ckj/sfaf346
Cardiac impact of dapagliflozin in advanced chronic kidney disease: rationale and design of the Renal Lifecycle Trial cardiac imaging sub-studiesÂ
doi : 10.1093/ckj/sfaf376
Deprivation and limitations in daily life in new onset kidney disease: a population studyÂ
doi : 10.1093/ckj/sfaf397
The electronic frailty index indicates mortality risk in end stage kidney disease patients on haemodialysis: retrospective survival analyses using linked data from two sourcesÂ
doi : 10.1093/ckj/sfaf355
Antidepressant prescriptions by provider in patients with kidney failure and depressionÂ
doi : 10.1093/ckj/sfaf374
Personalized virtual reality in hemodialysis patients: a multicenter pilot studyÂ
doi : 10.1093/ckj/sfaf367
Individualizing Kt by sex and body surface area: implications for survival in hemodialysis patientsÂ
doi : 10.1093/ckj/sfaf369
Comparable rates of catheter-related bloodstream infections between non-tunneled and tunneled hemodialysis catheters: a retrospective single-center studyÂ
doi : 10.1093/ckj/sfaf392
Intradialytic hypotension is severely underreported by intermittent blood pressure readingsÂ
doi : 10.1093/ckj/sfaf337
Outcomes of diabetic patients undergoing peritoneal dialysis in the French Language Peritoneal Dialysis RegistryÂ
doi : 10.1093/ckj/sfaf382
Decommissioning retired hemodialysis machines in Dutch hospitals: strategies and sustainability considerationsÂ
doi : 10.1093/ckj/sfaf389
Intradialytic exercise: a controlled nationwide effectiveness-implementation studyÂ
doi : 10.1093/ckj/sfaf361
Changing microbiology and outcomes of PD-associated peritonitis over four decadesÂ
doi : 10.1093/ckj/sfaf387
Glycaemic control and complications in haemodialysis patients: the TURK-HEMODIAB StudyÂ
doi : 10.1093/ckj/sfaf120
Patient’s view on: “Low-protein diet with personalized support in advanced chronic kidney disease: association with disease progression, dialysis delay, and mortalityâ€�Â
doi : 10.1093/ckj/sfaf385
Reframing incremental peritoneal dialysis: prioritizing minimum glucose exposure to preserve residual kidney functionÂ
doi : 10.1093/ckj/sfaf365
A peritoneal effluent sequencing assay that removes environmental DNA contamination in peritoneal dialysis patientsÂ
doi : 10.1093/ckj/sfaf358
Dapaglifozin use in pediatric IgA nephropathy: a single-center real-life experienceÂ
doi : 10.1093/ckj/sfaf395
